Saudi - Delayed Quote SAR

Nahdi Medical Company (4164.SR)

122.20
+0.40
+(0.33%)
At close: May 15 at 3:17:46 PM GMT+3
Currency in SAR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
9,446,420.05
9,446,420.05
8,713,675.99
8,616,187.82
8,066,215.38
Cost of Revenue
5,913,553.66
5,913,553.66
5,191,432.33
5,070,796.61
4,761,534.26
Gross Profit
3,532,866.39
3,532,866.39
3,522,243.66
3,545,391.21
3,304,681.12
Operating Expense
2,667,559.91
2,667,559.91
2,564,419.52
2,547,948.49
2,430,510.38
Operating Income
865,306.48
865,306.48
957,824.13
997,442.72
874,170.74
Net Non Operating Interest Income Expense
-65,067.20
-65,067.20
-26,203.48
-69,044.62
-75,919.55
Pretax Income
834,543.62
834,543.62
944,246.16
937,925.39
857,266.73
Tax Provision
13,820
13,820
51,628.02
50,113.58
44,738.10
Net Income Common Stockholders
820,723.62
820,723.62
892,618.14
887,811.81
812,528.63
Diluted NI Available to Com Stockholders
820,723.62
820,723.62
892,618.14
887,811.81
812,528.63
Basic EPS
6.31
--
6.87
6.83
6.25
Diluted EPS
6.31
--
6.87
6.83
6.25
Basic Average Shares
130,000
--
130,000
130,000
130,000
Diluted Average Shares
130,000
--
130,000
130,000
130,000
Total Operating Income as Reported
873,194.41
873,194.41
960,955.04
1,002,577.40
919,568.91
Total Expenses
8,581,113.57
8,581,113.57
7,755,851.86
7,618,745.09
7,192,044.64
Net Income from Continuing & Discontinued Operation
820,723.62
820,723.62
892,618.14
887,811.81
812,528.63
Normalized Income
817,641.52
817,641.52
891,942.68
878,030.96
766,096.77
Interest Income
50,799.97
50,799.97
56,818.52
12,129
2,962.02
Interest Expense
73,719.32
73,719.32
50,463.40
50,471.43
78,881.57
Net Interest Income
-65,067.20
-65,067.20
-26,203.48
-69,044.62
-75,919.55
EBIT
908,262.94
908,262.94
994,709.55
988,396.82
936,148.30
EBITDA
1,611,701.73
1,611,701.73
1,612,790.07
1,585,039.79
1,507,648.60
Reconciled Cost of Revenue
5,913,553.66
5,913,553.66
5,191,432.33
5,070,796.61
4,761,534.26
Reconciled Depreciation
703,438.79
703,438.79
618,080.52
596,642.97
571,500.30
Net Income from Continuing Operation Net Minority Interest
820,723.62
820,723.62
892,618.14
887,811.81
812,528.63
Total Unusual Items Excluding Goodwill
3,134
3,134
714.52
10,332.94
48,988.41
Total Unusual Items
3,134
3,134
714.52
10,332.94
48,988.41
Normalized EBITDA
1,608,567.73
1,608,567.73
1,612,075.55
1,574,706.84
1,458,660.19
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
51.90
51.90
39.07
552.09
2,556.55
12/31/2021 - 4/18/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade